Navigation Links
Concentric Medical Announces First Stroke Patients Treated in Canada with Trevo™ System
Date:1/26/2011

MOUNTAIN VIEW, Calif., Jan. 26, 2011 /PRNewswire/ -- Marking a major milestone toward expanding the use of Stentriever™ technology for stroke patients, Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Canada.  The Trevo System is an innovative, high-performing, easy-to-use system that utilizes Stentriever technology for the removal of clots that cause stroke. The Trevo Retriever is the first licensed retriever in Canada utilizing this technology.

On December 7, 2010, The Trevo System, which includes a Trevo™ device, Trevo™ 18 Microcatheter and DAC™ catheter, was licensed by Health Canada for stroke patients. The Trevo™ device was approved for thrombus retrieval. The DAC, previously approved as a distal support catheter, has now been approved for aspiration of thrombus in the neurovasculature. The Trevo System is now available to Canadian stroke centers.

Mayank Goyal, M.D., Clinical Professor, Department of Radiology, Foothills Medical Centre in Calgary Canada, was the first North American clinician to use the Trevo System.  Upon completion of one of the first cases, Dr. Goyal said, "We treated an 82-year-old woman who presented with right hemiparesis and aphasia. CTA showed clot in the M2 division of the left MCA. Given the patient's age and tortuosity, the new Trevo System was remarkably effective. I was able to achieve recanalization in a surprisingly short period of time.  The Trevo was also very easy to use; this is key in being able to rapidly restore blood flow for patients suffering an acute ischemic stroke."

Concentric Medical is the pioneer in developing devices for ischemic stroke intervention. Since 2004, Concentric Medical's devices have been used in thousands of stroke patients worldwide. This experience has been incorporated into the design of the Trevo System to make thrombus removal an easier, faster and a more predictable procedure.  

Maria Sainz, President and CEO of Concentric Medical, said, "The experience with the Trevo System in Canada and Europe is extremely encouraging.  This technology represents an exciting opportunity for Concentric Medical, one that has the potential to greatly expand the treatment of stroke. We are committed to bringing innovative tools and clinical evidence to clinicians globally to drive the adoption of interventional treatment for stroke patients."

Concentric Medical currently markets the Trevo System, the Merci Retriever®, Balloon Guide Catheters and the DAC family of catheters. These offerings represent an unparalleled array of choices for physicians involved in the treatment of ischemic stroke.

About Concentric MedicalConcentric Medical is located in Mountain View, California and is the global leader in the development of endovascular devices for revascularizing stroke patients.  The company manufactures and markets solutions for ischemic stroke: minimally invasive devices that are delivered into the brain to restore blood flow by removing blood clots that cause ischemic stroke.  Concentric Medical's devices are available in over 500 leading stroke centers around the world, and have been the subject of several clinical studies.  For more information about Concentric Medical, please visit www.concentric-medical.com.

About Acute Ischemic StrokeStroke is the third leading cause of death in the developed world and the leading cause of serious long-term disability.  Ischemic stroke represents over 85% of strokes and occurs when a blockage or clot develops in one of the arteries supplying blood to the brain.  In 2004 the FDA cleared Concentric Medical's Merci Retriever for use in patients who are ineligible for IV-tPA or who fail to respond to IV-tPA therapy.  This pioneering device created a departure from the historic method of caring for stroke patients and offered physicians and patients a long-awaited option for stroke intervention.Media Contact: +1 650-938-2100strokeinfo@concentric-medical.com
'/>"/>

SOURCE Concentric Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
2. Concentric Medical Announces Product and Procedure Reimbursement as Well as Full Commercialization of the Merci Retriever® in Japan
3. Concentric Medical and the Merci Retrieval System(R) Highlighted at the 2010 International Stroke Conference
4. Concentric Medical to Sponsor Randomized Trial
5. Solta Medical Announces Full Year and Fourth Quarter 2010 Results Release and Conference Call
6. Rochester Medical Reports First Quarter Results and Recent Developments
7. Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers
8. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
9. Cutting Edge Nanotech Patents for Displays, Lighting, X-ray, Medical Imaging, and Diagnostics Available for Sale by ICAP Ocean Tomo
10. High Tech Vet Medical Warming System Introduced at Orlando
11. Home Medical Equipment Group Asks President Obama to Review Patchwork of Ineffective Medicare Regulations for Home-Based Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
Breaking Medicine News(10 mins):